Literature DB >> 20863487

Effect of double-stranded DNA on maturation of dendritic cells in vitro.

Ekaterina A Alyamkina1, Olga Y Leplina, Ludmila V Sakhno, Elena R Chernykh, Alexandr A Ostanin, Yaroslav R Efremov, Alexandr G Shilov, Anastasia S Proskurina, Konstantin E Orishchenko, Evgenia V Dolgova, Vladimir A Rogachev, Valeriy P Nikolin, Nelly A Popova, Stanislav N Zagrebelniy, Sergey S Bogachev, Mikhail A Shurdov.   

Abstract

A preparation of human genomic fragmented double-stranded DNA (dsDNA) was used as maturation stimulus in cultures of human dendritic cells (DCs) generated in compliance with the interferon protocol. Culturing of the DCs in medium with 5μg/ml of the DNA preparation was associated with a decrease in the relative proportion of CD14 + cells and an increase in that of CD83 + cells. These changes are markers of DC maturation. The efficiency with which the DNA preparation was able to elicit DC maturation was commensurate with that of lypopolysaccharide from bacterial cell, the standard inducer of DC maturation. Generated ex vivo, matured in the presence of the human DNA preparation, pulsed with tumor antigens mouse DCs were used as a vaccine in biological tests for its antitumor activity. The experimental results demonstrate that reinfusion of mature pulsed with tumor antigens DCs cause a statistically significant suppression of tumor graft growth.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20863487     DOI: 10.1016/j.cellimm.2010.08.011

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  5 in total

1.  Chronometric Administration of Cyclophosphamide and a Double-Stranded DNA-Mix at Interstrand Crosslinks Repair Timing, Called "Karanahan" Therapy, Is Highly Efficient in a Weakly Immunogenic Lewis Carcinoma Model.

Authors:  Vera Ruzanova; Anastasia Proskurina; Yaroslav Efremov; Svetlana Kirikovich; Genrikh Ritter; Evgenii Levites; Evgenia Dolgova; Ekaterina Potter; Oksana Babaeva; Sergey Sidorov; Oleg Taranov; Alexandr Ostanin; Elena Chernykh; Sergey Bogachev
Journal:  Pathol Oncol Res       Date:  2022-05-27       Impact factor: 2.874

2.  A strategy of tumor treatment in mice with doxorubicin-cyclophosphamide combination based on dendritic cell activation by human double-stranded DNA preparation.

Authors:  Ekaterina A Alyamkina; Valeriy P Nikolin; Nelly A Popova; Evgenia V Dolgova; Anastasia S Proskurina; Konstantin E Orishchenko; Yaroslav R Efremov; Elena R Chernykh; Alexandr A Ostanin; Sergey V Sidorov; Dmitriy M Ponomarenko; Stanislav N Zagrebelniy; Sergey S Bogachev; Mikhail A Shurdov
Journal:  Genet Vaccines Ther       Date:  2010-11-01

3.  Combination of cyclophosphamide and double-stranded DNA demonstrates synergistic toxicity against established xenografts.

Authors:  Ekaterina A Alyamkina; Valeriy P Nikolin; Nelly A Popova; Alexandra M Minkevich; Artem V Kozel; Evgenia V Dolgova; Yaroslav R Efremov; Sergey I Bayborodin; Oleg M Andrushkevich; Oleg S Taranov; Vladimir V Omigov; Vladimir A Rogachev; Anastasia S Proskurina; Evgeniy I Vereschagin; Elena V Kiseleva; Maria V Zhukova; Alexandr A Ostanin; Elena R Chernykh; Sergey S Bogachev; Mikhail A Shurdov
Journal:  Cancer Cell Int       Date:  2015-03-19       Impact factor: 5.722

4.  Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer.

Authors:  Anastasia S Proskurina; Tatiana S Gvozdeva; Ekaterina A Alyamkina; Evgenia V Dolgova; Konstantin E Orishchenko; Valeriy P Nikolin; Nelly A Popova; Sergey V Sidorov; Elena R Chernykh; Alexandr A Ostanin; Olga Y Leplina; Victoria V Dvornichenko; Dmitriy M Ponomarenko; Galina S Soldatova; Nikolay A Varaksin; Tatiana G Ryabicheva; Peter N Uchakin; Stanislav N Zagrebelniy; Vladimir A Rogachev; Sergey S Bogachev; Mikhail A Shurdov
Journal:  BMC Cancer       Date:  2015-03-13       Impact factor: 4.430

5.  mTOR Inhibitors Can Enhance the Anti-Tumor Effects of DNA Vaccines through Modulating Dendritic Cell Function in the Tumor Microenvironment.

Authors:  Yu-Li Chen; Han-Wei Lin; Nai-Yun Sun; Jr-Chi Yie; Hsueh-Chih Hung; Chi-An Chen; Wei-Zen Sun; Wen-Fang Cheng
Journal:  Cancers (Basel)       Date:  2019-05-02       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.